What is the main business of Genozym?

The main business activity of Genozym focuses on manufacture of other inorganic basic chemicals.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on August 27, 2007.

Where is the headquarters located?

The headquarters is located at: Gryglewskiego 10, 80-303 Gdańsk.

Who is on the management board?

The management board includes Piotr Mariusz Skowron (President of the Management Board).

What is the share capital?

The share capital of the company is PLN 200,000 (approx. $54,025).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.

What revenue was generated?

The company reported a revenue of $7,517 in 2024, which is a decrease of 85.6% compared to 2023.

No, in 2024 the company reported a net loss of $262.

What is the main operating cost?

The largest operating cost category falls under depreciation and amortization. This category amounted to $7,562 in 2024, representing 97% of all operating expenses.

Genozymsp. z o.o.

Manufacture of other inorganic basic chemicals

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2007-08-27

Share capital

200,000.00 PLN

Registered address

Gryglewskiego 10/21, 80-303 Gdańsk, Poland

Financials

Revenue history (in k)

Filing timeliness

No financial statement for 2025 – the filing deadline has passed. 2 of 6 financial statements were filed late (the longest delay 47 days for 2021).

2025not filed
202426/07/2025
202313/07/2024
202229/06/2023
202131/08/2022
202027/03/2021

Filed on timeDelayFiling deadline

The statements for 2018–2022 report only zeros (no activity).

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2024.

Results vs industry

Revenue

This companyUSD 7.52kMedianUSD 956.06kAverageUSD 16.93m

Net profit

This companyUSD -261.78MedianUSD 7.86kAverageUSD 67.14k

Operating costs

This companyUSD 7.78kMedianUSD 869.08kAverageUSD 14.54m

Assets

This companyUSD 28.86kMedianUSD 1.19mAverageUSD 29.72m

Industry

Authorized Representatives

Henryk Jan Wlazło – Attorney-in-fact (sole)

Piotr Mariusz Skowron – President of the Management Board

Manner of representation

President of the Management Board independently; two members of the management board jointly, or one member of the management board jointly with a commercial proxy

Supervisory board

Robert Adam Gis – Supervisory Board Member

Beata Krupińska – Supervisory Board Member

Helena Skowron – Supervisory Board Member

Ownership

Owner	Shares	Share value	Stake
Beata Krupińskaage 48	51	$6,888.17	12.75%
Piotr Mariusz Skowronage 64	231	$31,199.35	57.75%
Tomasz Szreder	80	$10,804.97	20%
Others	38	$5,132.36	9.5%

Beneficial owners

Person	Rights

Bank accounts

Was a VAT taxpayer from 2023-09-15 to 2025-06-11.

Reason for removal: Art. 96 ust. 9a pkt 3 (VAT returns showing no transactions filed for 6 consecutive months or 2 quarters)

Debt

No entries in the National Debtors Register (KRZ).

Public aid

Grant date	Purpose	Gross amount	Granting body
Mar 17, 2023	De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)	$35,696$35,696	Excento sp. z o.o.

Competitors

Name	Revenue	Website
Wytwórnia Pianek Poliuretanowychsp. z o.o.	$3,156,383.24	pianki-pur.com.pl
NatalexS.A.	$2,007,075.39	natalex.com.pl
Smart NanotechnologiesS.A.	$1,162,260.91	smartnanotechnologies.com.pl
Arkemik Kobel ArkadiuszS.K.A.	$1,042,259.07	arkemik.pl
CTS Chemistrysp. z o.o.	$795,057.73	ctschemistry.com
Marbet Wilsp. z o.o.	$580,209.09	marbetwil.pl
Tangerine Dreamsp. z o.o.	$503,586.26	tangerine.com.pl
WABA Bissp. z o.o.	$327,786.45	waba.com.pl
Purovetsp. z o.o.	$29,501.17	purovet.pl
Detalabsp. z o.o.	$6,171.65	detalab.pl